A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/27 (2006.01) A61P 25/28 (2006.01)
Patent
CA 2634166
The subject invention provides a method of preventing a neurodegenerative disease in a subject or oxidative stress in the brain of a subject, comprising administering to the subject a less than cholinesterase-inhibitory amount or a less than monoamine oxidase-inhibitory amount of R(+)-6-(N-methyl,N-ethyl-1- carbamoyloxy)-N'-propargyl-1-aminoindan or a salt thereof effective to prevent the neurodegenerative disease or oxidative stress in the subject.
La présente invention concerne un procédé de prévention chez un sujet d'une maladie dégénérative du système nerveux ou d'un stress oxydatif cérébral. Ledit procédé comprend l'administration au sujet d'une quantité de R(+)-6-(N-méthyl,N-éthyl-1-carbamoyloxy)-N'-propargyl-1-aminoindane ou d'un de ses sels inférieure à la quantité capable d'inhiber la cholinestérase ou la monoamine oxydase, afin de prévenir de manière efficace la maladie dégénérative du système nerveux ou le stress oxydatif chez le sujet.
Borden Ladner Gervais Llp
Technion Research And Development Foundation Ltd
Yissum Research Development Company Of The Hebrew University Of
LandOfFree
Use of low-dose ladostigil for neuroprotection does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of low-dose ladostigil for neuroprotection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of low-dose ladostigil for neuroprotection will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1544163